Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.11%7.19B | 1.69%2.86B | 14.16%7.57B | 2.58%2.81B | 7.82%6.63B | 4.58%2.74B | 19.63%6.15B | --4.24B | 27.30%2.62B | 20.34%5.14B |
| Operating income | -5.11%7.19B | 1.69%2.86B | 14.16%7.57B | 2.58%2.81B | 7.82%6.63B | 4.58%2.74B | 19.63%6.15B | 27.30%2.62B | 20.34%5.14B | |
| Cost of sales | 8.37%-3.57B | -3.87%-1.4B | -23.45%-3.89B | -7.35%-1.35B | -19.61%-3.15B | -15.39%-1.25B | -38.60%-2.64B | ---- | -48.74%-1.09B | -14.69%-1.9B |
| Operating expenses | 8.37%-3.57B | -3.87%-1.4B | -23.45%-3.89B | -7.35%-1.35B | -19.61%-3.15B | -15.39%-1.25B | -38.60%-2.64B | -1.72B | -48.74%-1.09B | -14.69%-1.9B |
| Gross profit | -1.66%3.62B | -0.32%1.46B | 5.76%3.68B | -1.44%1.46B | -1.01%3.48B | -3.09%1.49B | 8.51%3.52B | 2.52B | 15.49%1.53B | 23.93%3.24B |
| Selling expenses | 10.74%-1.45B | 11.25%-601.89M | 8.19%-1.62B | 13.01%-678.17M | 1.10%-1.77B | 10.68%-779.63M | 1.78%-1.79B | ---1.4B | -11.85%-872.86M | -26.20%-1.82B |
| Administrative expenses | -24.88%-879.81M | -10.22%-305.47M | -10.79%-704.52M | -11.61%-277.15M | -10.57%-635.91M | -2.78%-248.33M | -15.50%-575.15M | ---373.12M | -11.92%-241.61M | -10.28%-497.98M |
| Research and development expenses | -0.54%-301.92M | -12.46%-125.56M | 1.88%-300.29M | 17.61%-111.65M | -1.84%-306.05M | -16.26%-135.51M | -53.15%-300.51M | ---198.77M | -45.44%-116.56M | -28.64%-196.21M |
| Impairment and provision | 2.35%-44.47M | -16.14%-15.97M | 36.07%-45.54M | -6.21%-13.75M | -128.37%-71.24M | 8.79%-12.95M | -183.68%-31.19M | ---- | -2,504.04%-14.19M | 50.41%-11M |
| -Other impairment is provision | 2.35%-44.47M | -16.14%-15.97M | 36.07%-45.54M | -6.21%-13.75M | -128.37%-71.24M | 8.79%-12.95M | -183.68%-31.19M | ---- | -2,504.04%-14.19M | 50.41%-11M |
| Special items of operating profit | 45.04%112.43M | 80.50%46.93M | -67.83%77.52M | -15.14%26M | 164.11%240.93M | -15.80%30.64M | 48.16%91.22M | ---- | 65.75%36.39M | -8.94%61.57M |
| Operating profit | -2.56%1.06B | 11.76%457.57M | 15.38%1.09B | 20.52%409.43M | 3.02%941.6M | 4.86%339.71M | 17.50%913.96M | 19.00%323.96M | 26.52%777.82M | |
| Financing cost | -46.65%-71.01M | -23.85%-29.84M | -33.98%-48.42M | -53.32%-24.09M | -2.28%-36.14M | 34.36%-15.71M | 1.30%-35.34M | ---- | -42.88%-23.94M | -2.36%-35.8M |
| Share of profits of associates | 7.02%-13.1M | -54.44%-7.47M | 1.50%-14.09M | -211.17%-4.84M | -265.97%-14.3M | -2.03%4.35M | 23.79%8.62M | ---- | 67.56%4.44M | 157.88%6.96M |
| Share of profit from joint venture company | 38.86%29.65M | -7.68%10.87M | -31.74%21.35M | -43.29%11.77M | -6.75%31.28M | 172.82%20.76M | -37.52%33.55M | ---- | -62.27%7.61M | 89.12%53.7M |
| Earning before tax | -3.93%1B | 9.91%431.13M | 13.31%1.05B | 12.37%392.27M | 0.18%922.44M | 11.87%349.11M | 14.72%920.79M | 12.13%312.08M | 34.64%802.68M | |
| Tax | -104.95%-339.58M | -5.25%-90.09M | -13.25%-165.69M | -27.91%-85.6M | 11.63%-146.31M | 6.43%-66.92M | -27.70%-165.56M | ---- | -44.84%-71.52M | -7.46%-129.64M |
| After-tax profit from continuing operations | -24.44%664.54M | 11.21%341.04M | 13.32%879.54M | 8.68%306.67M | 2.77%776.13M | 17.31%282.18M | 12.21%755.24M | 5.08%240.55M | 41.54%673.04M | |
| Earning after tax | -24.44%664.54M | 11.21%341.04M | 13.32%879.54M | 8.68%306.67M | 2.77%776.13M | 17.31%282.18M | 12.21%755.24M | 394.1M | 5.08%240.55M | 41.54%673.04M |
| Minority profit | -28.71%337.12M | 11.08%169.04M | 16.72%472.89M | -2.93%152.18M | 11.63%405.16M | 21.94%156.77M | 7.61%362.96M | ---- | 5.28%128.57M | 28.76%337.29M |
| Profit attributable to shareholders | -19.48%327.43M | 11.33%171.99M | 9.62%406.65M | 23.19%154.5M | -5.43%370.97M | 11.99%125.41M | 16.84%392.28M | 182.2M | 4.84%111.99M | 57.20%335.75M |
| Basic earnings per share | -19.69%1.02 | 12.50%0.54 | 9.48%1.27 | 23.08%0.48 | -5.69%1.16 | 11.43%0.39 | 17.14%1.23 | 6.06%0.35 | 56.72%1.05 | |
| Diluted earnings per share | -19.69%1.02 | 12.50%0.54 | 9.48%1.27 | 23.08%0.48 | -5.69%1.16 | 11.43%0.39 | 17.14%1.23 | 6.06%0.35 | 56.72%1.05 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | CAS (2007) | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |
| Auditor | ShinWing Certified Public Accountants (Special General Partnership) | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- | ShinWing Certified Public Accountants (Hong Kong) Limited | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.